Bluestar BioAdvisors
Boutique life sciences strategy consultancy advising biopharma and med‑device clients on portfolio strategy, business development, commercial planning, pricing and market access. Services emphasize market and technical analysis, primary and secondary research, financial valuation, and actionable go‑to‑market recommendations. The firm has multi‑regional experience including long‑standing work in China.
Industries
Nr. of Employees
small (1-50)
Bluestar BioAdvisors
Services
Market landscape evaluation, patient journey, commercial potential analysis and deliverables including forecasts and clinical development considerations.
Frameworks to compare lifecycle indications, prioritize R&D or in‑licensing, and define success criteria for assets or therapeutic areas.
Database searches, asset profiling, outreach to asset holders, and financial sensitivity analyses to support licensing and acquisition.
Competitive scenario development, simulation workshops, messaging and tactical plans to prepare for launch and commercialization.
Payer research, pricing benchmarking, GTN guidance, and coverage optimization recommendations.
Market landscape evaluation, patient journey, commercial potential analysis and deliverables including forecasts and clinical development considerations.
Frameworks to compare lifecycle indications, prioritize R&D or in‑licensing, and define success criteria for assets or therapeutic areas.
Database searches, asset profiling, outreach to asset holders, and financial sensitivity analyses to support licensing and acquisition.
Competitive scenario development, simulation workshops, messaging and tactical plans to prepare for launch and commercialization.
Payer research, pricing benchmarking, GTN guidance, and coverage optimization recommendations.
Expertise Areas
- Portfolio strategy and prioritization
- Business development and asset acquisition
- Commercial and launch planning
- Pricing and market access
Key Technologies
- Quantitative online surveys
- Conjoint analysis
- Epidemiology and prevalence modeling
- NPV and financial valuation modeling
News & Updates
Announcement that Brad Ship was named Managing Director and member of the leadership team.
Hosted an industry networking event with leadership team and industry guests.
Team packed gift bags for families staying at Ronald McDonald House.
Celebrated opening of new office space in New York City.
Partner Paul Zhang moderated a panel on the innovative pharmaceutical market in China during the China Focus conference.
Article by a firm partner discussing opportunities and risks in China's pharmaceutical market, published in In Vivo (Informa Pharma Intelligence).
Announcement that Brad Ship was named Managing Director and member of the leadership team.
Hosted an industry networking event with leadership team and industry guests.
Team packed gift bags for families staying at Ronald McDonald House.
Celebrated opening of new office space in New York City.
Partner Paul Zhang moderated a panel on the innovative pharmaceutical market in China during the China Focus conference.
Article by a firm partner discussing opportunities and risks in China's pharmaceutical market, published in In Vivo (Informa Pharma Intelligence).